Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

We explore the immense potential of gamma delta T cells, and the challenges in sourcing and scaling up sufficient volumes to ...

RAPT Therapeutics’ CEO Brian Wong said there was no “viable path forward” for the compound. Image credit: Shutterstock/Andrii Yalanskyi. RAPT Therapeutics has called it quits on a clinical programme ...

Paratek’s Nuzyra is approved by the US Food and Drug Administration (FDA) as a treatment for community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections ...

At the Outsourcing in Clinical Trials Conference in New England, experts shared insights on how the US clinical trial and ...